Cezanne predicts progression and adjuvant TACE response in hepatocellular carcinoma

We have previously reported that Cezanne could be a prognostic biomarker for survival in hepatocellular carcinoma (HCC) patients. However, the role of Cezanne genes in HCC cells and its response to postoperative adjuvant transcatheter arterial chemoembolization (TACE) in HCC patients remains unknown...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cell Death Dis
Autori principali: Wang, Jia-hong, Zhong, Xiao-ping, Zhang, Yong-fa, Wu, Xiao-liang, Li, Shao-hua, Jian, Pei-en, Ling, Yi-hong, Shi, Ming, Chen, Min-shan, Wei, Wei, Guo, Rong-ping
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group 2017
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5636974/
https://ncbi.nlm.nih.gov/pubmed/28880268
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cddis.2017.428
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi